A Phase II, randomized, open-label, multi-center study of JSB462 (luxdegalutamide) in combination with abiraterone in adult male patients with metastatic hormone-sensitive prostate cancer (mHSPC)

  • Herbison, Harriet (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date27/08/25 → 26/08/30

Clinical Trial Phase

  • Phase II